These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15225773)
21. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Ruggiero M; Pacini S; Aterini S; Fallai C; Ruggiero C; Pacini P Oncol Res; 1998; 10(1):43-6. PubMed ID: 9613456 [TBL] [Abstract][Full Text] [Related]
22. The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism. Sosa M; Torres A; Martín N; Salido E; Limiñana JM; Barrios Y; De Miguel E; Betancor P J Intern Med; 2000 Jan; 247(1):124-30. PubMed ID: 10672140 [TBL] [Abstract][Full Text] [Related]
23. Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women. Mitra S; Desai M; Ikram Khatkhatay M Maturitas; 2006 Aug; 55(1):27-35. PubMed ID: 16464547 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Mimbacas A; Trujillo J; Gascue C; Javiel G; Cardoso H Genet Mol Res; 2007 Sep; 6(3):534-42. PubMed ID: 17985306 [TBL] [Abstract][Full Text] [Related]
25. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns. Laaksonen MM; Outila TA; Karkkainen MU; Kemi VE; Rita HJ; Perola M; Valsta LM; Lamberg-Allardt CJ J Nutrigenet Nutrigenomics; 2009; 2(2):55-63. PubMed ID: 19690432 [TBL] [Abstract][Full Text] [Related]
26. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Lemos MC; Fagulha A; Coutinho E; Gomes L; Bastos M; Barros L; Carrilho F; Geraldes E; Regateiro FJ; Carvalheiro M Hum Immunol; 2008 Feb; 69(2):134-8. PubMed ID: 18361940 [TBL] [Abstract][Full Text] [Related]
27. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611 [TBL] [Abstract][Full Text] [Related]
28. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500 [TBL] [Abstract][Full Text] [Related]
29. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Yaylim-Eraltan I; Arzu Ergen H; Arikan S; Okay E; Oztürk O; Bayrak S; Isbir T Cell Biochem Funct; 2007; 25(6):731-7. PubMed ID: 17243190 [TBL] [Abstract][Full Text] [Related]
30. Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Rezende VB; Barbosa F; Montenegro MF; Sandrim VC; Gerlach RF; Tanus-Santos JE Arch Toxicol; 2008 Jan; 82(1):29-36. PubMed ID: 17701399 [TBL] [Abstract][Full Text] [Related]
31. Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis. de Souza CM; Braosi AP; Luczyszyn SM; Avila AR; de Brito RB; Ignácio SA; Probst CM; Riella MC; Sotomaior VS; Mira MT; Pecoits-Filho R; Trevilatto PC Blood Purif; 2007; 25(5-6):411-9. PubMed ID: 17914260 [TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Fang Y; Rivadeneira F; van Meurs JB; Pols HA; Ioannidis JP; Uitterlinden AG Bone; 2006 Oct; 39(4):938-45. PubMed ID: 16769262 [TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Panierakis C; Goulielmos G; Mamoulakis D; Petraki E; Papavasiliou E; Galanakis E Clin Immunol; 2009 Nov; 133(2):276-81. PubMed ID: 19734102 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Verbeek W; Gombart AF; Shiohara M; Campbell M; Koeffler HP Biochem Biophys Res Commun; 1997 Sep; 238(1):77-80. PubMed ID: 9299455 [TBL] [Abstract][Full Text] [Related]
35. Correlation between Vitamin D receptor gene FOKI and BSMI polymorphisms and the susceptibility to pulmonary tuberculosis in an Indonesian Batak-ethnic population. Sinaga BY; Amin M; Siregar Y; Sarumpaet SM Acta Med Indones; 2014 Oct; 46(4):275-82. PubMed ID: 25633543 [TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphism (SNP) allele frequency estimation in DNA pools using Pyrosequencing. Lavebratt C; Sengul S Nat Protoc; 2006; 1(6):2573-82. PubMed ID: 17406511 [TBL] [Abstract][Full Text] [Related]
37. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease. Bregenzer N; Schäffler A; Gelbmann CM; Steinkamp M; Reinshagen M; Schölmerich J; Andus T Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):1-5. PubMed ID: 16450309 [TBL] [Abstract][Full Text] [Related]
38. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Lombard Z; Dalton DL; Venter PA; Williams RC; Bornman L Hum Immunol; 2006 Aug; 67(8):643-54. PubMed ID: 16916662 [TBL] [Abstract][Full Text] [Related]
39. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Santonocito C; Capizzi R; Concolino P; Lavieri MM; Paradisi A; Gentileschi S; Torti E; Rutella S; Rocchetti S; Di Carlo A; Di Stasio E; Ameglio F; Zuppi C; Capoluongo E Br J Dermatol; 2007 Feb; 156(2):277-82. PubMed ID: 17223867 [TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]